This study estimated the efficacy of sublingual nifedipine 10 mg vs. sublingual lacidipine 4
mg in the management of hypertensive crises. We studied 40 patients with diastolic blood …

Nilvadipine is a new calcium antagonist of the dihydropyridine type. It reduces blood
pressure by high-affinity blockade of calcium channels in arterial cells, which leads to …

The long-term tolerability and antihypertensive effect of lercanidipine, a new calcium-entry
blocker, was evaluated in this open, multicenter study. A total of 355 mild to moderately …

Twenty-three middle-aged men (59+/-2 years) with sustained, essential hypertension (WHO
Stage II) and with diastolic blood pressure exceeding 100mmHg during a run-in placebo …

Lercanidipine is a vasoselective dihydropyridine calcium antagonist which causes systemic
vasodilation by blocking the influx of calcium ions through L-type calcium channels in cell …

A number of studies have shown short term hemodynamic and symptomatic improvement in
patients with essential hypertension under treatment with diltiazem. The long-term efficacy of …

1. The calcium-channel blocking activity of lacidipine has been studied compared with that
of nifedipine and verapamil on the isolated rabbit heart and aorta. 2. All the compounds …

Characteristics of three different calcium antagonist groups: Most important calcium
antagonists used to treat cardiovascular disease belong to one of three main groups …

The antihypertensive efficacy and tolerability of the new calcium antagonist isradipine was
assessed in 86 hypertensive patients who had pretreatment diastolic blood pressures …

The vasoprotective activity of lacidipine has been demonstrated both in animals and
humans. Results from several studies indicate that vital organ perfusion is maintained, or …